Overview
Diego di Sabato, M.D., serves as the Surgical Director of Liver Transplantation for both adult and pediatric patients at MUSC, a position that allows him to make a significant impact on patient care. He is developing a robust Living Donor Liver Transplant (LDLT) program and works with multidisciplinary teams including MUSC Health's Transplant Oncology practice, the Pediatric Liver Transplant Program, and other LDLT indications.Dr. di Sabato joined MUSC from the University of Chicago School of Medicine, where, since 2019, he served as the co-director of the Living Donor Liver Transplant (LDLT) Program. During his tenure at the University of Chicago School of Medicine, he relaunched the LDLT program after a 5-year hiatus, building it into one of the busiest LDLT programs in the region, with surgical outcomes that have met or exceeded national standards. As a pediatric transplant surgeon, he integrated live donor liver transplants and established a multidisciplinary approach to pediatric liver diseases, with excellent outcomes considering the complex population. The impact of the LDLT program now contributes to more than half of the pediatric liver transplants, including for acute liver failure in children, as well as an essential component of their novel Transplant Oncology program.Dr. di Sabato is exceedingly well trained, having completed two fellowships in Transplantation at Northwestern University Feinberg School of Medicine. He was also a visiting surgeon at the world's busiest living donor liver transplant program, Asan Medical Center, in Seoul, South Korea, the first center in the world to perform living donor liver transplantation.Along with his dedication to his clinical work, Dr. di Sabato is passionate about continued research to improve care for transplant patients. Currently, he is investigating liver recovery options in order to increase the number of viable organs available for patients needing a liver transplant.
Dr. Di Sabato is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Hepatitis, Liver Cancer, Fibrolamellar Carcinoma, Liver Transplant, and Kidney Transplant.
He is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
135 Rutledge Ave, 1st Floor, 9th Floor, Charleston, SC 29425
Additional Areas of Focus
Dr. Di Sabato has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MUSC Health Cardiology At West Ashley Medical Pavilion
Dr. Daniel Judge is a professor of medicine in cardiology at MUSC. He received his medical degree at the University of Pennsylvania, and did his post-graduate training in internal medicine, cardiology, and advanced heart failure/transplant cardiology at Johns Hopkins. He is board-certified in both cardiology and advanced heart failure/transplant cardiology.Dr. Judge takes care of adult patients with inherited forms of cardiovascular disease, as well as congestive heart failure. As director of the cardiovascular genetics program, Dr. Judge has extensive experience caring for individuals and families with inherited forms of cardiomyopathy, aortic aneurysm, amyloidosis, and cardiac involvement from other genetic conditions.He has authored more than 150 scientific manuscripts. Dr. Judge is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation. Dr. Judge is currently accepting new patients.
MUSC Health Cardiology At Ashley River Tower
Dr. Zile is a graduate of Rush University School of Medicine. He did his internal medicine residency at Rush Presbyterian St. Lukes Medical Center in Chicago, a clinical cardiology fellowship at Tufts-New England Medical Center in Boston and a research cardiology fellowship at the Department of Veterans Affairs Medical Center, Boston. Dr. Zile is currently the Charles Ezra Daniel professor of medicine at the Medical University of South Carolina.He also serves as the director of cardiology at the Ralph H. Johnson Department of Veteran's Affairs Medical Center in Charleston. He is an adjunct professor of bioengineering at Clemson University.Dr. Zile's research career has involved both basic laboratory research examining the mechanisms of disease development and progression and translational clinical research examining the application of these basic mechanisms to development of effective treatment methods.Dr. Zile is a recognized leader in the areas of cardiac function, congestive heart failure, diastolic heart failure and valvular heart disease. His research is supported by grants from the National Heart, Lung and Blood Institute, the American Heart Association, the Department of Veterans Affairs and the Medical University of South Carolina.Dr. Zile is the author of over 100 peer-reviewed publications. He is a member of a number of professional societies including the American College of Physicians, American Federation of Clinical Research, American Heart Association, American College of Cardiology, the Heart Failure Society of America, International Society of Heart Failure, and the American Physiology Society. Dr. Zile has served on the research, educational and program committees of these organizations. He serves on the editorial boards of the Journal of the American College of Cardiology and Circulation and is an editorial consultant to a number of others including Circulation Research, Journal of Clinical Investigation and the American Journal of Physiology. Dr. Zile is a member of the Association of University Cardiologists and a member of the ABIM Subspecialty Board on Cardiovascular Disease. Dr. Zile is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Hypertensive Heart Disease, Pacemaker Implantation, and Cardiac Ablation. Dr. Zile is currently accepting new patients.
MUSC Health Cardiology At Ashley River Tower
Dr. Tedford is a Professor of Medicine/Cardiology and holds the Dr. Peter C. Gazes Endowed Chair in Heart Failure at the Medical University of South Carolina (MUSC) in Charleston, SC. He currently serves as the section head of heart failure and medical director of cardiac transplantation. He also established and directs the Advanced Heart Failure and Transplant Fellowship Program at MUSC. Dr. Tedford is an internationally recognized clinical researcher and has published over 200 peer-reviewed original research manuscripts, invited expert reviews, editorials and book chapters. His research efforts are focused on hemodynamic assessment of right ventricle function and its interaction with the pulmonary circulation and left heart. This research spans the fields of pulmonary hypertension, left heart disease, exercise physiology, hemodynamics, systemic sclerosis and mechanical circulatory support. He participates on several scientific advisory boards, clinical trial steering committees, and serves as a hemodynamic core laboratory for clinical pharmaceutical trials. He is co-chair of the PH due to left heart disease task force for 7^th^ World Symposium on Pulmonary Hypertension. He is a deputy editor for the *Journal of Heart and Lung Transplantation* and serves on the editorial board for *Circulation: Heart Failure CHEST*and *JACC: Heart* *Failure.*. Dr. Tedford is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Hypertension, Heart Failure, Heart Transplant, and Cardiac Ablation. Dr. Tedford is currently accepting new patients.
Frequently Asked Questions about Dr. Diego Di Sabato
How do I make an appointment with Dr. Diego Di Sabato?
You can book an appointment with Dr. Diego Di Sabato by calling their office at 843-792-6100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Diego Di Sabato a top-rated expert for Hepatitis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Diego Di Sabato is classified as an Advanced expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Diego Di Sabato specialize in?
While Dr. Diego Di Sabato is a Transplant Surgery, they have specific expertise in Hepatitis, Liver Transplant, and Kidney Transplant. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Transplant Surgery.
Does Dr. Diego Di Sabato participate in research or clinical trials?
Yes. Dr. Diego Di Sabato has published 12 articles and abstracts on conditions like Hepatitis. You can view a list of Dr. Diego Di Sabato's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Diego Di Sabato accept my insurance?
Dr. Diego Di Sabato accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 843-792-6100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- HepatitisDr. Di Sabato isAdvanced. Learn about Hepatitis.
- Liver TransplantDr. Di Sabato isAdvanced. Learn about Liver Transplant.
- Experienced
- Alcoholic CirrhosisDr. Di Sabato isExperienced. Learn about Alcoholic Cirrhosis.
- Bile Duct StrictureDr. Di Sabato isExperienced. Learn about Bile Duct Stricture.
- Caroli DiseaseDr. Di Sabato isExperienced. Learn about Caroli Disease.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Di Sabato isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- CholestasisDr. Di Sabato isExperienced. Learn about Cholestasis.
- Chronic Antibody-Mediated RejectionDr. Di Sabato isExperienced. Learn about Chronic Antibody-Mediated Rejection.